Swiss Dental Startup vVardis Is Preparing for US IPO

Swiss dental startup vVardis is preparing for an initial public offering in the United States, Bloomberg reports.

The company, which develops dental care technology, is laying the groundwork for a listing on a US exchange, according to Bloomberg's report. No timeline, target valuation, or offering size was disclosed.

A US IPO would place vVardis among the relatively small number of European health-tech companies that have chosen American markets over domestic exchanges. The move comes as investors continue to weigh a selective reopening of the IPO window after a prolonged drought in new listings.

Bloomberg did not report which banks, if any, have been mandated to advise on the offering, and vVardis has not commented publicly on the timing or scale of a potential float.

If the listing proceeds, vVardis would join the ranks of Swiss startups testing investor appetite for specialised medical technology on Wall Street — a market that has recently rewarded niche healthcare names with credible growth stories. Whether the dental care segment can command a premium valuation will depend on the financial details the company discloses as the process advances.